Gennex Laboratories Quarterly Results for Trading Insights
GENNEX • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹6 Cr
QSept 2025
Gennex Laboratories Quarterly Results Key Highlights
- Revenue of ₹37 Cr in Sept 2025 (-15.9% vs Mar 2025, +15.6% vs Sept 2024)
- Net Profit of ₹6 Cr in Sept 2025 (+100.0% vs Mar 2025, +20.0% vs Sept 2024)
- EBITDA of ₹6 Cr in Sept 2025 (+0.0% vs Mar 2025)
- Operating Margin of 15.0% in Sept 2025 (+10.0pp vs Mar 2025)
- Earnings Per Share of ₹0.21 in Sept 2025 (+50.0% vs Mar 2025)
Gennex Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 37 | 44 | 37 | 40 | 32 | -15.9% | 15.6% |
| Net Profit (₹ Cr) | 6 | 3 | 5 | 6 | 5 | - | - |
| EBITDA (₹ Cr) | 6 | 6 | 7 | 6 | 6 | - | - |
| EPS (₹) | 0.21 | 0.14 | 0.22 | 0.22 | 0.21 | - | - |
| Operating Margin (%) | 15.0% | 5.0% | 15.0% | 14.0% | 18.0% | - | - |
Gennex Laboratories Share Price Trend Around Quarterly Results
Visualize Gennex Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Gennex Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Gennex Laboratories
Additional stock information and data for GENNEX
Revenue Trend (₹ Cr)
Dec 2025
40
Jun 2025
37
Mar 2025
44
Sept 2025
37
Net Profit Trend (₹ Cr)
Dec 2025
6
Jun 2025
5
Mar 2025
3
Sept 2025
6
Operating Margin Trend (%)
Dec 2025
14.0%
Jun 2025
15.0%
Mar 2025
5.0%
Sept 2025
15.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Gennex Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1825.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 140.5 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6352.5 | 2,860 | 689 | +7.1% | - | 24.1% | 244.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4431.2 | 3,219 | 591 | +11.3% | - | 18.4% | 252.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1325.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1329.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores